SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp of America Holdings – ‘10-K405/A’ for 12/31/98 – EX-10.36

As of:  Friday, 3/12/99   ·   For:  12/31/98   ·   Accession #:  920148-99-9   ·   File #:  1-11353

Previous ‘10-K405’:  ‘10-K405’ on 3/11/99 for 12/31/98   ·   Latest ‘10-K405’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

 3/12/99  Lab Corp of America Holdings      10-K405/A  12/31/98   19:254K

Amendment to Annual Report — [x] Reg. S-K Item 405   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K405/A   Amendment to Annual Report -- [x] Reg. S-K Item       83    361K 
                          405                                                    
 2: EX-10.34    Material Contract                                      7     34K 
 3: EX-10.35    Material Contract                                      1     10K 
 4: EX-10.36    Material Contract                                      2     14K 
 5: EX-10.37    Material Contract                                      2     12K 
 6: EX-10.38    Material Contract                                      7     30K 
 7: EX-12.1     Statement re: Computation of Ratios                    2     11K 
 8: EX-23.1     Consent of Experts or Counsel                          1      9K 
 9: EX-23.2     Consent of Experts or Counsel                          1     10K 
10: EX-24.1     Power of Attorney                                      6     24K 
11: EX-27.1     Financial Data Schedule (Pre-XBRL)                     2     11K 
12: EX-27.2     Financial Data Schedule (Pre-XBRL)                     2      9K 
13: EX-27.3     Financial Data Schedule (Pre-XBRL)                     2      9K 
14: EX-27.4     Financial Data Schedule (Pre-XBRL)                     2      9K 
15: EX-27.5     Financial Data Schedule (Pre-XBRL)                     2      9K 
16: EX-27.6     Financial Data Schedule (Pre-XBRL)                     2      9K 
17: EX-27.7     Financial Data Schedule (Pre-XBRL)                     2      9K 
18: EX-27.8     Financial Data Schedule (Pre-XBRL)                     2      9K 
19: EX-27.9     Financial Data Schedule (Pre-XBRL)                     2      9K 


EX-10.36   —   Material Contract

EX-10.361st Page of 2TOCTopPreviousNextBottomJust 1st
 

EXHIBIT 10.36 AMENDMENT TO SUPPORT AGREEMENT THIS AMENDMENT TO SUPPORT AGREEMENT ("Agreement") made as of this 1st day of January, 1997 by and between Laboratory Corporation of America Holdings, successor to Roche Biomedical Laboratories, Inc. ("LabCorp"), Hoffmann-La Roche Inc. ("Roche"), Roche Molecular Systems, Inc. ("RMS") and Roche Diagnostic Systems, Inc. ("RDS"). WITNESSETH: WHEREAS, LabCorp and Roche previously entered into a Support Agreement dated April 27, 1995 (the "Support Agreement"); and WHEREAS, subject to the terms and conditions contained herein, the parties wish to amend the Support Agreement and add RDS and RMS as parties to the Support Agreement. NOW THEREFORE, in consideration of the mutual representations, warranties, covenants and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows: 1. The parties agree that RDS and RMS are added as a parties to the Support Agreement and that the words, "RMS and RDS' shall be added after the word "Roche" wherever such word appears in the paragraphs 1A., 1B., and 7 (in its entirety). Notwithstanding anything contained in the Support Agreement to the contrary, LabCorp agrees that Roche, RMS and RDS shall not be jointly liable in the event of any breach or other claim, but each shall be severally liable for solely their own respective acts or omissions, if any. The parties further agree that the word "RBL" shall be replaced with the word "LabCorp" throughout the Support Agreement. Any notices sent to RDS shall be sent to Roche Diagnostic Systems, Inc. 1080 US Highway 202, Branchburg, N.J. 08876-1080 Attn: President with a copy to the General Counsel, 340 Kingsland Street, Nutley, N.J. 07110. Any notices sent to RMS shall be sent to Roche Molecular Systems, Inc. 1080 US Highway 202, Branchburg, N.J. 08876-1080 Attn: President with a copy to the General Counsel, 340 Kingsland Street, Nutley, N.J. 07110. 2. The parties agree that the first sentence of subparagraph A of paragraph 3 shall be deleted in its entirety and in lieu thereof the following sentence shall be added: "The parties agree that Roche shall provide payroll services solely for Lab Delivery Services of New York City, Inc. on behalf of LabCorp until such time as the parties mutually agree."
EX-10.36Last Page of 2TOC1stPreviousNextBottomJust 2nd
2. LabCorp agrees that Roche, RMS and RDS will be providing certain services, including but not limited to the use of office space, office staff, telephone, photocopying, limousine and aircraft services, if any, for Thomas P. Mac Mahon, LabCorp's Chief Executive Officer. LabCorp agrees to pay Roche, RMS and RDS for any and all reasonable charges which Roche, RMS and RDS shall each determine for such services, which in no event shall exceed the fair market value of such services. Such charges shall be paid on a quarterly basis. RMS, RDS and Roche shall submit invoices to LabCorp for such charges. 3. The parties further agree that paragraphs 2,4,5,6 B shall be deleted in their entirety from the Support Agreement. Except as modified herein, the remaining terms and provisions of the Support Agreement are hereby ratified, confirmed and remain in full force and effect. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective duly authorized representatives as of the date first written above. HOFFMANN - LA ROCHE INC. LABORATORY CORPORATION OF AMERICA HOLDINGS By: _________________________ By:__________________________ ROCHE DIAGNOSTIC SYSTEMS, INC. By: _________________________ ROCHE MOLECULAR SYSTEMS, INC. By: _________________________

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘10-K405/A’ Filing    Date First  Last      Other Filings
Filed on:3/12/99
For Period End:12/31/9810-K405
4/27/9518-B12B/A
 List all Filings 
Top
Filing Submission 0000920148-99-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 9:11:27.1am ET